LADENBURG THALMANN FINANCIAL SERVICES INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 43 filers reported holding ONCOCYTE CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2019$1,000
-80.0%
500
-80.0%
0.00%
Q3 2019$5,000
-73.7%
2,500
-66.7%
0.00%
Q2 2019$19,000
+850.0%
7,500
+1400.0%
0.00%
Q1 2019$2,000
+100.0%
5000.0%0.00%
Q4 2018$1,0000.0%5000.0%0.00%
Q3 2018$1,0000.0%5000.0%0.00%
Q2 2018$1,0000.0%5000.0%0.00%
Q1 2018$1,000
-50.0%
5000.0%0.00%
Q4 2017$2,000500
+2281.0%
0.00%
Q3 2016$0210.0%0.00%
Q2 2016$0210.0%0.00%
Q1 2016$0210.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders